118 related articles for article (PubMed ID: 1654925)
1. Reduced ACTH/cortisol responses to naloxone in men with Parkinson's disease.
Volpi R; Caffarra P; Marcato A; Scaglioni A; Maestri D; Delsignore R; Chiodera P; Coiro V
J Neural Transm Park Dis Dement Sect; 1991; 3(2):127-32. PubMed ID: 1654925
[TBL] [Abstract][Full Text] [Related]
2. Restoration of ACTH/cortisol and LH responses to naloxone by chronic dopaminergic treatment in Parkinson's disease.
Volpi R; Caffarra P; Scaglioni A; Maestri D; Chiodera P; Coiro V
J Neural Transm Park Dis Dement Sect; 1994; 7(1):1-11. PubMed ID: 8579765
[TBL] [Abstract][Full Text] [Related]
3. Lack of ACTH/cortisol and GH responses to intravenously-infused substance P in Parkinson's disease.
Volpi R; Caffarra P; Scaglioni A; Saginario A; Maestri D; Vourna S; Vescovi PP; Chiodera P; Coiro V
J Neural Transm Park Dis Dement Sect; 1993; 6(2):99-107. PubMed ID: 7509607
[TBL] [Abstract][Full Text] [Related]
4. ACTH/cortisol involvement in the serotonergic disorder affecting the parkinsonian brain.
Volpi R; Caffarra P; Boni S; Scaglioni A; Malvezzi L; Saginario A; Chiodera P; Coiro V
Neuropsychobiology; 1997; 35(2):73-8. PubMed ID: 9097297
[TBL] [Abstract][Full Text] [Related]
5. The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: interaction with endogenous opioid peptides.
Inder WJ; Joyce PR; Ellis MJ; Evans MJ; Livesey JH; Donald RA
Clin Endocrinol (Oxf); 1995 Sep; 43(3):283-90. PubMed ID: 7586596
[TBL] [Abstract][Full Text] [Related]
6. Effect of naloxone on oxytocin-induced cortisol decrease in normal men.
Coiro V; Chiodera P; Rossi G; Volpi R; Salvi M; Camellini L; Roti E
Acta Endocrinol (Copenh); 1985 Feb; 108(2):261-5. PubMed ID: 2982243
[TBL] [Abstract][Full Text] [Related]
7. Naloxone decreases the inhibitory effect of alprazolam on the release of adrenocorticotropin/cortisol induced by physical exercise in man.
Coiro V; Volpi R; Casti A; Maffei ML; Stella A; Volta E; Chiodera P
Br J Clin Pharmacol; 2011 Jun; 71(6):951-5. PubMed ID: 21564163
[TBL] [Abstract][Full Text] [Related]
8. Oxytocin reduces exercise-induced ACTH and cortisol rise in man.
Coiro V; Passeri M; Davoli C; Bacchi-Modena A; Bianconi L; Volpi R; Chiodera P
Acta Endocrinol (Copenh); 1988 Nov; 119(3):405-12. PubMed ID: 2847472
[TBL] [Abstract][Full Text] [Related]
9. Luteinizing hormone and cortisol responses to naloxone in normal weight women with bulimia.
Coiro V; d'Amato L; Marchesi C; Capretti L; Volpi R; Roberti G; Cerri L; Chiodera P
Psychoneuroendocrinology; 1990; 15(5-6):463-70. PubMed ID: 2101966
[TBL] [Abstract][Full Text] [Related]
10. Different effects of baclofen on LH and cortisol responses to naloxone in normal men.
Coiro V; Volpi R; Marcato A; Bertoni P; Cavazzini U; Caffarri G; Capretti L; Rossi G; Chiodera P
Psychoneuroendocrinology; 1992 Nov; 17(6):667-71. PubMed ID: 1337607
[TBL] [Abstract][Full Text] [Related]
11. Effect of sodium valproate on naloxone-stimulated ACTH and cortisol release in humans.
Torpy DJ; Grice JE; Hockings GI; Crosbie GV; Walters MM; Jackson RV
Clin Exp Pharmacol Physiol; 1995; 22(6-7):441-3. PubMed ID: 8582096
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man.
Inder WJ; Ellis MJ; Evans MJ; Donald RA
Clin Endocrinol (Oxf); 1995 Oct; 43(4):425-31. PubMed ID: 7586616
[TBL] [Abstract][Full Text] [Related]
13. Elevated basal adrenocorticotropin and evidence for increased central opioid tone in highly trained male athletes.
Inder WJ; Hellemans J; Ellis MJ; Evans MJ; Livesey JH; Donald RA
J Clin Endocrinol Metab; 1995 Jan; 80(1):244-8. PubMed ID: 7829620
[TBL] [Abstract][Full Text] [Related]
14. Diurnal effects of fluoxetine and naloxone on the human hypothalamic-pituitary-adrenal axis.
Torpy DJ; Grice JE; Hockings GI; Walters MM; Crosbie GV; Jackson RV
Clin Exp Pharmacol Physiol; 1997 Jun; 24(6):421-3. PubMed ID: 9171947
[TBL] [Abstract][Full Text] [Related]
15. Plasma profiles of adrenocorticotropic hormone, cortisol, growth hormone and prolactin in patients with untreated Parkinson's disease.
Bellomo G; Santambrogio L; Fiacconi M; Scarponi AM; Ciuffetti G
J Neurol; 1991 Feb; 238(1):19-22. PubMed ID: 1851513
[TBL] [Abstract][Full Text] [Related]
16. Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans.
Dorin RI; Ferries LM; Roberts B; Qualls CR; Veldhuis JD; Lisansky EJ
J Clin Endocrinol Metab; 1996 Nov; 81(11):3883-91. PubMed ID: 8923833
[TBL] [Abstract][Full Text] [Related]
17. L-type calcium channels and CRH-mediated ACTH and cortisol release in humans.
Hockings GI; Grice JE; Walters MM; Jackson RV
Clin Exp Pharmacol Physiol; 1991 May; 18(5):303-7. PubMed ID: 1648460
[TBL] [Abstract][Full Text] [Related]
18. Diurnal variations in endocrine and psychological responses to 0.2 mg/kg naloxone administration in patients with major depressive disorder and matched controls.
MartÃn del Campo AF; Dowson JH; Herbert J; Paykel ES
J Affect Disord; 2000; 57(1-3):37-47. PubMed ID: 10708814
[TBL] [Abstract][Full Text] [Related]
19. Dopamine infusion enhances the adrenocorticotropic hormone and cortisol response to metoclopramide in hyperprolactinemic patients but not in normal subjects.
Moro M; Maraschini C; Cavagnini F
Gynecol Endocrinol; 1997 Jun; 11(3):155-62. PubMed ID: 9209895
[TBL] [Abstract][Full Text] [Related]
20. Effect of flumazenil on basal and naloxone-stimulated ACTH and cortisol release in humans.
Torpy DJ; Jackson RV; Grice JE; Hockings GI; Crosbie GV; Walters MM
Clin Exp Pharmacol Physiol; 1994 Feb; 21(2):157-61. PubMed ID: 8039271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
